Rubus imperialis
Rubus imperialis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Rubus imperialis is a botanical species of significant interest due to its diverse pharmacological potential. Research focusing on its leaves, stems, and roots has revealed important antidiabetic and cytotoxic activities. Specific preparations, such as the ethyl acetate extract and the butanol fraction derived from the roots, have been studied for their bioactive properties. These studies highlight the presence of key chemical compounds, including Niga-ichigoside F1 and 23-hydroxytormentic acid. Ultimately, these components play a crucial role in regulating blood glucose levels and influencing processes like efferocytosis.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Rosaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Taxonomy
Rubus imperialis is a notable member of the kingdom Plantae, representing the diverse life found within the botanical world. This species belongs to the class Equisetopsida and falls under the specific order Rosales. Within this taxonomic hierarchy, it is categorized under the family Rosaceae, a group known for many familiar flowering plants. It further identifies with the genus Rubus, which connects it to a wide array of brambles and berries. Through these biological classifications, one can better understand the unique evolutionary position of this plant.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Rosaceae |
| Genus | Rubus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Rubus imperialis maintains a diverse geographic presence across several regions of South America. In the eastern portions of the continent, the species is widely distributed throughout Brazil, specifically within the southern and southeastern territories. Its reach extends into the southern reaches of the continent, where it can be found in both the northeast and northwest regions of Argentina. Additionally, the plant establishes itself within the western landscapes of South America, particularly throughout Bolivia. This broad distribution highlights the adaptability of the species across varied South American climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Rubus imperialis typically presents as a sturdy shrub, providing a structured presence within its natural habitat. However, it also possesses a facultative climbing habit, allowing it to scale surrounding vegetation when necessary.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Rubus imperialis has demonstrated significant biological potential through various scientific screenings and assays. Research involving the brine shrimp microwell cytotoxicity assay revealed that certain extracts, specifically the methanolic extract and ethyl acetate fraction from the roots, exhibit notable cytotoxic activity. Beyond these effects, in vivo studies have confirmed the plant's powerful hypoglycemic properties. These findings provide scientific validation for the traditional use of the species as an effective antidiabetic agent in Brazilian folk medicine. Ultimately, the phytochemical analysis of this plant highlights its diverse pharmacological importance.
Compounds
Rubus imperialis serves as the botanical source for the triterpene glycoside known as niga-ichigoside F1. This specific compound was successfully isolated from the ethyl acetate extract of the plant's aerial parts. Scientific evaluations have highlighted its significant potential for managing pain through antinociceptive activity. In laboratory models, the substance demonstrated the ability to inhibit both the first and second phases of pain. These findings suggest that niga-ichigoside F1 is a potent bioactive component derived from this plant species.
Conditions
Rubus imperialis demonstrates significant antioxidant potential through its ability to treat DPPH radicals and provide cytoprotection against H2O2-induced oxidative stress. The plant also exhibits antinociceptive properties, specifically treating the HOAc-induced writhing model. Research into its components shows that isolated compounds like 2β,3β-19α-trihydroxyursolic acid can be safely tested in HepG2/C3A cells without inducing cytogenotoxic effects. Furthermore, the methanolic extract of the plant acts as an antidiabetic agent by confirming its hypoglycemic activity.
Preparations
Rubus imperialis is prepared as various extracts and fractions to evaluate its diverse medicinal properties. Research utilizes Rubus imperialis prepared as an extract, such as methanolic versions from different plant parts, to study wound healing and hypoglycemic effects. The plant is also prepared as an EtOAc extract to isolate specific compounds like niga-ichigoside F1 for antinociceptive testing. Furthermore, Rubus imperialis is prepared as a butanol fraction from roots and an ethyl acetate fraction from roots to screen for cytotoxicity. Finally, the plant is prepared as a hexane fraction from roots to facilitate comprehensive phytochemical and biological analyses.
Parts used
Rubus imperialis is a medicinal plant of the Rosaceae family that possesses several biologically active components. Scientific research indicates that the plant's therapeutic properties can be derived from various anatomical structures, specifically the leaf, root, and stem. Studies on methanolic extracts from these different parts have revealed significant anti-inflammatory, wound-healing, and antinociceptive effects. Furthermore, investigations into the roots and stems have highlighted the plant's potential for hypoglycemic activity, supporting its traditional use as an antidiabetic agent. By analyzing these specific parts, researchers continue to uncover the complex phytochemical profile that makes this species so valuable for medical applications.